Sarepta Therapeutics
SRPT
$126.82
Share price
-1.58%
Change (1 day)
69.89%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Operating Margin for Sarepta Therapeutics (SRPT)
Operating Margin as of May 2023 (TTM): -112.59%
According to Sarepta Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -112.59%. At the end of 2021 the company had an Operating Margin of -50.64%.
Operating Margin history for Sarepta Therapeutics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -50.64% | -44.54% |
| 2020 | -91.30% | -49.11% |
| 2019 | -179.40% | 64.2% |
| 2018 | -109.26% | 294.18% |
| 2017 | -27.72% | -99.43% |
| 2016 | -4,873.31% | -72.27% |
| 2015 | -17,572.55% | 1181.54% |
| 2014 | -1,371.21% | 115.95% |
| 2013 | -634.95% | 697.97% |
| 2012 | -79.57% | 4.07% |
| 2011 | -76.46% | 7.45% |
| 2010 | -71.16% | -19.31% |
| 2009 | -88.18% | 6.87% |
| 2008 | -82.52% | -72.62% |
| 2007 | -301.38% | -98.95% |
| 2006 | -28,608.52% | 7713.06% |
| 2005 | -366.16% | -93.71% |
| 2004 | -5,817.95% | 198.97% |
| 2003 | -1,945.99% | -35.74% |
| 2002 | -3,028.39% | 38.83% |
| 2001 | -2,181.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 26.86% | -123.86% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -77.95% | -30.77% | 🇺🇸 USA |
 Novavax NVAX | -149.57% | 32.84% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -100.93% | -10.36% | 🇺🇸 USA |
 Insmed INSM | -231.56% | 105.67% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -77.02% | -31.59% | 🇺🇸 USA |
 Avidity Biosciences RNA | -1,886.32% | 1,575.39% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.